Home » Stocks » Ekso Bionics Holdings

Ekso Bionics Holdings, Inc. (EKSO)

Stock Price: $7.35 USD 0.12 (1.66%)
Updated Jul 2, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 55.79M
Revenue (ttm) 11.77M
Net Income (ttm) -8.12M
Shares Out 7.59M
EPS (ttm) -1.59
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Jul 2, 2020
Last Price $7.35
Previous Close $7.23
Change ($) 0.12
Change (%) 1.66%
Day's Open 7.16
Day's Range 7.16 - 7.94
Day's Volume 1,085,622
52-Week Range 2.25 - 19.65

More Stats

Market Cap 55.79M
Enterprise Value 50.48M
Earnings Date (est) Aug 11, 2020
Ex-Dividend Date n/a
Shares Outstanding 7.59M
Float 4.28M
EPS (basic) -1.64
EPS (diluted) -1.59
FCF / Share -2.13
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 294,166
Short Ratio 2.02
Short % of Float 5.49%
Beta 1.94
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 4.74
PB Ratio 5.20
Revenue 11.77M
Operating Income -16.51M
Net Income -8.12M
Free Cash Flow -12.37M
Net Cash 5.32M
Net Cash / Share 0.70
Gross Margin 57.47%
Operating Margin -140.28%
Profit Margin -69.00%
FCF Margin -105.11%
ROA -54.58%
ROE -166.26%
ROIC -116.20%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (2)

Buy 2
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$12.50*
(70.07% upside)
Low
12.0
Current: 7.35
High
13.0
Target: 12.50
*Average 12-month price target from 2 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year20192018201720162015201420132012
Revenue13.9211.337.3514.228.665.333.302.71
Revenue Growth22.81%54.11%-48.29%64.2%62.59%61.33%22.03%-
Gross Profit6.764.312.072.951.181.560.590.37
Operating Income-16.64-27.03-31.94-27.78-21.56-16.79-10.29-14.24
Net Income-12.13-26.99-29.12-23.47-19.59-33.77-11.89-15.04
Shares Outstanding4.794.082.371.210.970.750.200.19
Earnings Per Share-2.55-6.60-12.30-30.75-27.45-45.30-59.85-78.74
Operating Cash Flow-15.77-22.17-31.23-25.00-18.27-15.01-9.06-12.66
Capital Expenditures-0.06-0.13-0.46-1.10-1.49-1.49-0.38-0.83
Free Cash Flow-15.83-22.30-31.68-26.09-19.76-16.49-9.44-13.49
Cash & Equivalents10.877.6627.8116.8519.5525.190.811.74
Total Debt3.474.986.976.790.080.047.577.69
Net Cash / Debt7.412.6720.8410.0619.4725.15-6.76-5.96
Assets21.9217.6637.9924.4332.2033.476.586.21
Liabilities15.1214.9316.6017.8923.3910.6715.6314.62
Book Value6.802.7321.396.538.8122.80-36.37-25.09
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Ekso Bionics Holdings, Inc.
Country United States
Employees 67
CEO Jack Peurach

Stock Information

Ticker Symbol EKSO
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Unique Identifier NASDAQ: EKSO

Description

Ekso Bionics Holdings, Inc. designs, develops, and sells exoskeletons for use in the healthcare, industrial, and military markets in North America, Europe, the Middle East, and Africa. The company operates through EksoHealth and EksoWorks segments. It primarily offers Ekso GT, a bionic suit that provides the ability to stand and walk over ground with a reciprocal gait using a cane, crutches, or a walker to individuals with spinal cord injuries and hemiplegia due to stroke. The company's Ekso device is primarily used in a hospital and rehabilitation setting. The company has a license agreement with Lockheed Martin Corporation, Regents of the University of California, and Garrett Brown, as well as with OttoBock Healthcare Products Gmbh. The company was founded in 2005 and is headquartered in Richmond, California.